AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34615593 — intervention group
Group type: COMPARATOR
Intervention: Intracutaneous suturing
Number of subjects: 156
Study 32702892 — intervention group
Group type: EXPERIMENTAL
Intervention: Lefamulin
Number of subjects: 1289
Study 32702892 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 1289
Study 35006304 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 68
Study 34827492 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercise using a real-time postural feedback system
Number of subjects: 30
Study 34827492 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 33009840 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term Compassion Fatigue Resiliency Program (5 hr per day for 2 days, 10 hr total)
Number of subjects: 125
Study 33009840 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term Compassion Fatigue Resiliency Program (5 weeks, 2 hr per week, 10 hr total)
Number of subjects: 125
Study 33009840 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study 32305185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior repair
Number of subjects: 618
Study 32305185 — intervention group
Group type: COMPARATOR
Intervention: Posterior repair
Number of subjects: 618
Study 32773222 — intervention group
Group type: EXPERIMENTAL
Intervention: 2MACE score in patients with CKD
Number of subjects: 4554
Study 32773222 — intervention group
Group type: EXPERIMENTAL
Intervention: 2MACE score in patients without CKD
Number of subjects: 4554
Study 32773222 — intervention group
Group type: COMPARATOR
Intervention: CKD presence
Number of subjects: 4554
Study 32773222 — intervention group
Group type: COMPARATOR
Intervention: Overall incidence of cardiovascular mortality
Number of subjects: 4554
Study 32773222 — intervention group
Group type: COMPARATOR
Intervention: Overall incidence of non-cardiovascular mortality
Number of subjects: 4554
Study 32773222 — intervention group
Group type: COMPARATOR
Intervention: c-index of the 2MACE score for MACE
Number of subjects: 4554
Study 35468994 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-bout WBV
Number of subjects: 16
Study 35468994 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-bout WBV
Number of subjects: 16
Study 35468994 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 16
Study 32875813 — intervention group
Group type: COMPARATOR
Intervention: Treatment 1 (T1): Vaccinated against ND+IB on days 7 and 14;
Number of subjects: 108
Study 32875813 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment 2 (T2): Vaccinated against ND+IB on days 3 and 7, and IBD on day 14;
Number of subjects: 108
Study 32875813 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment 3 (T3): Vaccinated against ND+IB on days 7 and 21, and IBD on day 14;
Number of subjects: 108
Study 33709613 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 85
Study 33709613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 32997156 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone graft
Number of subjects: 62
Study 32997156 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenous bone graft
Number of subjects: 62
Study 32997156 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial bone graft
Number of subjects: 62
Study 32997156 — intervention group
Group type: COMPARATOR
Intervention: No bone graft
Number of subjects: 62
Study 34767967 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS therapy with individualized MRI guidance
Number of subjects: 49
Study 34767967 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp-targeting rules (e.g., Beam F3)
Number of subjects: 49
Study 34767967 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cm rule
Number of subjects: 49
Study 34767967 — intervention group
Group type: EXPERIMENTAL
Intervention: Seed-based connectivity analyses
Number of subjects: 49
Study 32360090 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB) and opioids if required
Number of subjects: 236
Study 32360090 — intervention group
Group type: COMPARATOR
Intervention: Conventional pain management using opioids if required
Number of subjects: 236
Study 32360090 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB) and opioids if required (subgroup analysis)
Number of subjects: 236
Study 32360090 — intervention group
Group type: COMPARATOR
Intervention: Conventional pain management using opioids if required (subgroup analysis)
Number of subjects: 236
Study 32360090 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 236
Study 36471691 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT + K + M (Stereotactic Body Radiation Therapy with Pembrolizumab and Trametinib)
Number of subjects: 147
Study 36471691 — intervention group
Group type: COMPARATOR
Intervention: SBRT + G (Stereotactic Body Radiation Therapy with Gemcitabine)
Number of subjects: 147
Study 36471691 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT + K + M
Number of subjects: 147
Study 36471691 — intervention group
Group type: COMPARATOR
Intervention: SBRT + G
Number of subjects: 147
Study 33190615 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTIV (Augmented Community Telerehabilitation Intervention)
Number of subjects: 95
Study 33190615 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 95
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline total metabolic tumor volume (TMTV) measured using SUV41max
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline total metabolic tumor volume (TMTV) measured using SUV4
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim PET response measured by ΔSUVmax
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim PET response measured by Deauville score
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high baseline TMTV and poor iPET response
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: TMTV by SUV41max
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: TMTV by SUV4
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: iPET response by ΔSUVmax
Number of subjects: 76
Study 32067259 — intervention group
Group type: EXPERIMENTAL
Intervention: iPET response by Deauville
Number of subjects: 76
Study 36331688 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted psychosocial intervention
Number of subjects: 0
Study 36331688 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving intervention by humans only
Number of subjects: 0
Study 34127252 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (SUG)
Number of subjects: 180
Study 34127252 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine (NEO)
Number of subjects: 180
Study 35296289 — intervention group
Group type: EXPERIMENTAL
Intervention: Information related to AstraZeneca's vaccine safety, misinformation, individual health risks, and public health risks.
Number of subjects: 0
Study 35296289 — intervention group
Group type: EXPERIMENTAL
Intervention: Information campaigns tailored for health workers.
Number of subjects: 0
Study 34003834 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 161
Study 32678785 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger roof hatch opening
Number of subjects: 0
Study 32678785 — intervention group
Group type: COMPARATOR
Intervention: Standard roof hatch opening (control)
Number of subjects: 0
Study 32891079 — intervention group
Group type: EXPERIMENTAL
Intervention: Affected side cross-training
Number of subjects: 52
Study 32891079 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaffected side cross-training
Number of subjects: 52
Study 32891079 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 32891079 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 52
Study 35087233 — intervention group
Group type: EXPERIMENTAL
Intervention: Convidecia (heterologous booster)
Number of subjects: 299
Study 35087233 — intervention group
Group type: COMPARATOR
Intervention: CoronaVac (homologous booster)
Number of subjects: 299
Study 33637064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronic acid (HA) treatment
Number of subjects: 60
Study 33637064 — intervention group
Group type: COMPARATOR
Intervention: Control group (TMJID patients)
Number of subjects: 60
Study 33923868 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Mindfulness-Based Stress Reduction (MBSR) and Mindful Self-Compassion (MSC) training program
Number of subjects: 112
Study 33923868 — intervention group
Group type: COMPARATOR
Intervention: Abbreviated Mindfulness-Based Stress Reduction (MBSR) and Mindful Self-Compassion (MSC) training program
Number of subjects: 112
Study 32396250 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% trichloroacetic acid (TCA) in four sessions within 4 weeks
Number of subjects: 60
Study 32396250 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy (Cryo) using liquid nitrogen in four sessions within 8 weeks
Number of subjects: 60
Study 35595375 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed Assent (IA) discussions about CPR
Number of subjects: 0
Study 35595375 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study 33962764 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral mediastinal lymphadenectomy (BML)
Number of subjects: 102
Study 33962764 — intervention group
Group type: COMPARATOR
Intervention: Standard lymphadenectomy (SLND)
Number of subjects: 102
Study 32073676 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers withdrawal
Number of subjects: 52
Study 32073676 — intervention group
Group type: COMPARATOR
Intervention: Control group (beta-blockers continued)
Number of subjects: 52
Study 36159218 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPAC in combination with systemic chemotherapy
Number of subjects: 0
Study 36159218 — intervention group
Group type: COMPARATOR
Intervention: Standard systemic chemotherapy
Number of subjects: 0
Study 33071207 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical glue (ethyl 2-cyanoacrylate; Glue group)
Number of subjects: 126
Study 33071207 — intervention group
Group type: COMPARATOR
Intervention: Catgut sutures (Suture group)
Number of subjects: 126
Study 35136595 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal home visits to pregnant women and their spouses (two-monthly visits)
Number of subjects: 6931
Study 34840289 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention for anger management (two individual monthly sessions by a psychologist)
Number of subjects: 90
Study 34840289 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 90
Study 34840289 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention for anger management
Number of subjects: 90
Study 34840289 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 33517977 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab
Number of subjects: 0
Study 33517977 — intervention group
Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 0
Study 34734306 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis
Number of subjects: 102
Study 34734306 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal anastomosis
Number of subjects: 102
Study 34038558 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal with 300 mL of tea
Number of subjects: 46
Study 34038558 — intervention group
Group type: COMPARATOR
Intervention: Test meal without tea
Number of subjects: 46
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 % ET
Number of subjects: 36
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 % ACT
Number of subjects: 36
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 % THF
Number of subjects: 36
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 % ET + 2 % DMSO (ET+DMSO)
Number of subjects: 36
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 % ethanol + 15 % THF (ET+THF)
Number of subjects: 36
Study 35830119 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 % THF + 2 % DMSO (THF+DMSO)
Number of subjects: 36
Study 32206888 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating bidirectional approach during the first session
Number of subjects: 96
Study 32206888 — intervention group
Group type: COMPARATOR
Intervention: Standard under-table approach during all sessions
Number of subjects: 96
Study 33274687 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 40
Study 33274687 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg
Number of subjects: 40
Study 33274687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36031523 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy for 4 minutes
Number of subjects: 94
Study 36031523 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular acupressure
Number of subjects: 94
Study 36031523 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 94
Study 34397687 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based nutritional counseling intervention
Number of subjects: 108
Study 34397687 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 108
Study 32374395 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cyclohexanone levels measured preoperatively, postoperatively, and 12 hours postoperatively
Number of subjects: 85
Study 32374395 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric mean cyclohexanone levels
Number of subjects: 85
Study 35242206 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation therapy
Number of subjects: 100
Study 35242206 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation therapy alone
Number of subjects: 100
Study 32564645 — intervention group
Group type: EXPERIMENTAL
Intervention: MPH (Methylphenidate)
Number of subjects: 362
Study 32564645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study 32558709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ga-exendin-4 PET/CT
Number of subjects: 52
Study 32558709 — intervention group
Group type: EXPERIMENTAL
Intervention: In-exendin-4 SPECT/CT
Number of subjects: 52
Study 35226737 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious sedation
Number of subjects: 345
Study 35226737 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 345
Study 33595906 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm entry antrostomy (test group)
Number of subjects: 20
Study 33595906 — intervention group
Group type: COMPARATOR
Intervention: 10 mm entry antrostomy (control group)
Number of subjects: 20
Study 35457524 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (brochure distributed)
Number of subjects: 208
Study 35457524 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 208
Study 32751463 — intervention group
Group type: EXPERIMENTAL
Intervention: High automation probability jobs
Number of subjects: 95762
Study 32751463 — intervention group
Group type: EXPERIMENTAL
Intervention: Low automation probability jobs
Number of subjects: 95762
Study 32751463 — intervention group
Group type: EXPERIMENTAL
Intervention: Later years of surveys
Number of subjects: 95762
Study 32751463 — intervention group
Group type: COMPARATOR
Intervention: Overall trends
Number of subjects: 95762
Study 35367657 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cathodal tDCS (1.5 mA, 20 min)
Number of subjects: 11
Study 35367657 — intervention group
Group type: COMPARATOR
Intervention: Sham cathodal tDCS
Number of subjects: 11
Study 33580553 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive face‐to‐face medicine management consultation with an integrated practice pharmacist within seven days of discharge, followed by a consultation with their general practitioner and further pharmacist consultations as needed.
Number of subjects: 306
Study 33580553 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 306
Study 33821507 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention featuring an adolescent girl with depression
Number of subjects: 1183
Study 33821507 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention featuring an adolescent boy with depression
Number of subjects: 1183
Study 33821507 — intervention group
Group type: COMPARATOR
Intervention: Video intervention featuring an adolescent girl without depression
Number of subjects: 1183
Study 33821507 — intervention group
Group type: COMPARATOR
Intervention: Video intervention featuring an adolescent boy without depression
Number of subjects: 1183
Study 33821507 — intervention group
Group type: EXPERIMENTAL
Intervention: All video interventions (depression conditions)
Number of subjects: 1183
Study 33821507 — intervention group
Group type: EXPERIMENTAL
Intervention: Racially congruent protagonists
Number of subjects: 1183
Study 32746928 — intervention group
Group type: COMPARATOR
Intervention: Nudging
Number of subjects: 455
Study 32746928 — intervention group
Group type: COMPARATOR
Intervention: Non-salient pricing strategies
Number of subjects: 455
Study 32746928 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of salient price increases and discounts
Number of subjects: 455
Study 32746928 — intervention group
Group type: EXPERIMENTAL
Intervention: Salient pricing and nudging strategies
Number of subjects: 455
Study 33686630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 100 µg
Number of subjects: 16
Study 33686630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 200 µg
Number of subjects: 16
Study 33686630 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (control)
Number of subjects: 16
Study 33686630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (both doses)
Number of subjects: 16
Study 32579971 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal-time photography (5.44% of meals)
Number of subjects: 137
Study 32579971 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking food photographs
Number of subjects: 137
Study 32579971 — intervention group
Group type: COMPARATOR
Intervention: Taking non-food photographs
Number of subjects: 137
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.i.d.
Number of subjects: 1947
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.i.d.
Number of subjects: 1947
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.i.d. (prior TNFi failure)
Number of subjects: 1947
Study 35380740 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.i.d. (prior TNFi failure)
Number of subjects: 1947
Study 35380740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1947
Study 36183850 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 42
Study 34507602 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide treated nets
Number of subjects: 0
Study 34507602 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 0
Study 35879705 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075% ropivacaine and 0.5 µg/mL sufentanil
Number of subjects: 103
Study 35879705 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine and 0.5 µg/mL sufentanil
Number of subjects: 103
Study 35879705 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 103
Study 33170938 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch (SEE)
Number of subjects: 50
Study 33170938 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective enamel etching + self-etch (SET)
Number of subjects: 50
Study 33170938 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse with dry dentin (ERDry)
Number of subjects: 50
Study 33170938 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse with wet dentin (ERWet)
Number of subjects: 50
Study 34999726 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual soccer game (experimental group)
Number of subjects: 40
Study 34999726 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33031130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led cardiac rehabilitation and routine care, including a booklet on cardiac rehabilitation and fortnightly telephone reminders.
Number of subjects: 0
Study 33031130 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 0
Study 33158406 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported experience of unwanted childbirth (UC)
Number of subjects: 14537
Study 33158406 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous experience of induced abortion, sexual violence, and threat from a partner
Number of subjects: 14537
Study 33158406 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported good health
Number of subjects: 14537
Study 34170736 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led educational intervention
Number of subjects: 92
Study 34170736 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 32928289 — intervention group
Group type: EXPERIMENTAL
Intervention: Bath at 24 hours after birth
Number of subjects: 0
Study 32928289 — intervention group
Group type: COMPARATOR
Intervention: Bath at 2 hours after birth
Number of subjects: 0
Study 32928289 — intervention group
Group type: COMPARATOR
Intervention: Bath at 6 hours after birth
Number of subjects: 0
Study 36067452 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line chemotherapy with cetuximab (anti-EGFR-chemotherapy)
Number of subjects: 292
Study 36067452 — intervention group
Group type: COMPARATOR
Intervention: First-line chemotherapy with bevacizumab (anti-VEGF-chemotherapy)
Number of subjects: 292